基本信息
浏览量:1
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
SUE ANN COSTA CLEMENS, MD, MSc, PhD, CBE
Sue Ann is Professor of Global Health and Vaccinology at University of Oxford and University of Siena, where she is the Head of the Institute for Global Health. In over 25 years of experience, she has contributed to the development of more than 20 globally licensed vaccines and pharmaceuticals. Vaccines she has worked on including Rotavirus, HPV, PCV and Covid-19 vaccines have saved millions of lives worldwide, reduced long term sequelae and disabilities and thus contributed to global health, one of her key missions and goals. Sue Ann was part of the development of the first vaccine that gained Emergency Use Listing by WHO, the new oral type 2 polio vaccine.
Sue Ann is one of the Principal Investigators of the Oxford/AstraZeneca vaccine clinical development. Sue Ann was appointed Commander of the Order of the British Empire, CBE, for services to Sciences and Public Health in 2021 by Queen Elizabeth II, and also appointed Commander of the Federal Republic of Brazil.
She has been contributing to teaching and capacity building in different areas, created the first Master in Vaccinology and Drug Development worldwide and published extensively on vaccinology and public health.
Sue Ann has been recently appointed as member of the WHO Technical Advisory Group on Market Access for Vaccines (TAG-MI4A).
She is the author of “History of a Vaccine”, the report of the Brazilian scientst who led the Oxford/AstraZeneca vaccine studies in the country, and co-author of “The First 100% Brazilian vaccine against COVID-19” , chapter: Clinical development.
Web of Science citation index: 146,966 (date of assessment: March 20, 2023)
Web of Science h-index: 150 (date of assessment: March 20, 2023)
Top 10% of Authors on SSRN by all-time downloads (date of assessment: March 3, 2023
SSRN's Top Ten list for: COVID-19 eJournal; paper: Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine (date of assessment: August 3rd, 2023); http://dx.doi.org/10.2139/ssrn.3777268
研究兴趣
论文共 78 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
npj vaccinesno. 1 (2024)
Vaccineno. 9 (2024): 2326-2336
Collins Ankunda, Stuart Martin Kanyesigye, Susan Nakubulwa, Brendah Kyomuhangi, Jakob Cramer,Enrique Chacon-Cruz,Sue Ann Costa Clemens,Ralf Clemens
JOURNAL OF INFECTION IN DEVELOPING COUNTRIESno. 4 (2024): 556-564
FRONTIERS IN PUBLIC HEALTH (2024): 1179268-1179268
The Lancet Microbeno. 8 (2024): 100863-100863
Deirdre F Foley,Timothy K Chege,Joyce Kabagenyi, Karen McCarthy,Elijah T Gicheru,Nelson Kibinge, Angela W Maina, Jacqueline M Waeni, Ralf Clemens,Sue-Ann Costa Clemens,James Tuju,Charles J Sande
crossref(2024)
Feyrouz Damji Kurji,Ananda Sankar Bandyopadhyay,Simona Zipursky,Laura V Cooper,Chris Gast, Margaret Toher,Ralf Clemens,Sue Ann Costa Clemens, Rayasam Prasad, Adriansjah Azhari
VACCINESno. 3 (2023): 645-645
Research Square (Research Square)no. 1 (2023): 1-8
加载更多
作者统计
#Papers: 71
#Citation: 7166
H-Index: 23
G-Index: 51
Sociability: 6
Diversity: 2
Activity: 145
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn